A Randomized, Multicenter, Single Blinded, ParallelStudy

Project: Research project

Project Details

Description

A Randomized, Multicenter, Single Blinded, ParallelStudy of the Safety of 100 mg and 200 mg OseltamivirAdministered Intravenously for the Treatment ofInfluenza in Patients Aged 13 Years
StatusFinished
Effective start/end date12/28/0912/31/12

Funding

  • HOFFMANN-LA ROCHE PHARMACEUTICALS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.